ICCM

IceCure Medical Ltd. Ordinary Shares (ICCM)

About IceCure Medical Ltd. Ordinary Shares (ICCM)

IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.

Details

Daily high

$1.19

Daily low

$1.11

Price at open

$1.15

52 Week High

$1.57

52 Week Low

$0.48

Market cap

61.4M

Dividend yield

0.00%

Volume

404,824

Avg. volume

591,689

P/E ratio

-3.92

IceCure Medical Ltd. Ordinary Shares News